{"id":"twice-daily-insulin","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common","effect":"Weight gain"},{"rate":"5–10","effect":"Injection site reactions"},{"rate":"variable","effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a peptide hormone that binds to insulin receptors on cell surfaces, enabling glucose transport into muscle, fat, and liver cells. This reduces blood glucose levels and promotes anabolic metabolism. Twice-daily dosing provides basal and prandial (meal-time) coverage to maintain glycemic control throughout the day.","oneSentence":"Insulin replaces or supplements the body's own insulin to regulate blood glucose by facilitating glucose uptake into cells and promoting glycogen synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:09.686Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"}]},"trialDetails":[{"nctId":"NCT07384052","phase":"PHASE1","title":"Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2026-02-20","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT05781711","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-01-06","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT05040321","phase":"PHASE1, PHASE2","title":"Sirtuin-NAD Activator in Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-12-01","conditions":"Alzheimer's Disease (Incl Subtypes), Dementia","enrollment":22},{"nctId":"NCT07461103","phase":"PHASE2","title":"Effect of Topical Insulin on Healing Rate of Pemphigus Lesions","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-22","conditions":"Pemphigus Vulgaris, Skin Erosion, Autoimmune Blistering Disease","enrollment":20},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT00743782","phase":"PHASE2","title":"Comparing Pump With Subcutaneous Injection Delivery of PTH 1-34 in the Management of Chronic Hypoparathyroidism","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2008-08-22","conditions":"Hypoparathyroidism, Hypocalcemia, Autoimmune Polyendocrine Syndrome Type 1","enrollment":21},{"nctId":"NCT00947726","phase":"NA","title":"Ceramide Containing Multivesicular Emulsion Application . . .","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2009-07","conditions":"Foot Transepidermal Water Loss in Patients in NIDDM, Foot Dryness in Patients With NIDDM","enrollment":10},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT07407699","phase":"NA","title":"Exercise, Insulin Resistance, and Chronic Pain in Postmenopausal Women.","status":"NOT_YET_RECRUITING","sponsor":"São Paulo State University","startDate":"2026-08","conditions":"Chronic Pain, Postmenopausal, Insulin Resistance","enrollment":50},{"nctId":"NCT04251585","phase":"PHASE2","title":"Intranasal Insulin in Parkinson's Disease","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2020-02-04","conditions":"Parkinson Disease","enrollment":31},{"nctId":"NCT07380841","phase":"NA","title":"Metformin vs Inositol vs Diet vs Combination Therapy in PCOS","status":"COMPLETED","sponsor":"Islamabad Medical and Dental College","startDate":"2025-05-21","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Metabolic Syndrome","enrollment":192},{"nctId":"NCT07379944","phase":"NA","title":"Guided Visualization Meditation for Reducing Surgical Stress Response in Cardiac Surgery Patients","status":"NOT_YET_RECRUITING","sponsor":"University of Gaziantep","startDate":"2026-01-15","conditions":"Cardiac Surgery, Surgical Stress Response, Coronary Artery Disease","enrollment":72},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT07307677","phase":"NA","title":"Melatonin & Metformin on Clinical & Biochemical Parameters in Insulin Resistant PCOS Compared to Metformin","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-03-11","conditions":"PCOS(Insulin Resistant)","enrollment":60},{"nctId":"NCT03999853","phase":"PHASE1, PHASE2","title":"Butyrate Adjuvant Therapy for Type 1 Diabetes","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-07-28","conditions":"Type1diabetes","enrollment":6},{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT03875755","phase":"NA","title":"Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-04","conditions":"Gestational Diabetes Mellitus","enrollment":1080},{"nctId":"NCT07247734","phase":"PHASE2","title":"The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation","status":"RECRUITING","sponsor":"Asger Lund, MD","startDate":"2025-12-01","conditions":"Type 1 Diabetes, Chronic Inflammation, Insulin Sensitivity","enrollment":26},{"nctId":"NCT07266259","phase":"NA","title":"Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women","status":"RECRUITING","sponsor":"Mst.Sumyara Khatun","startDate":"2025-09-19","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":72},{"nctId":"NCT07271199","phase":"NA","title":"Eyelash Effect Evaluation for Premium Rejuvenation Eyelash Serum","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hungkuang University","startDate":"2025-11-01","conditions":"Skin Condition, Eyelash Growth, Eyelashes","enrollment":30},{"nctId":"NCT03107884","phase":"EARLY_PHASE1","title":"Role of Metformin on Muscle Health of Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Muscle Atrophy, Insulin Resistance","enrollment":64},{"nctId":"NCT05417841","phase":"NA","title":"Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM","status":"COMPLETED","sponsor":"Beijing Hospital","startDate":"2023-03-23","conditions":"Type 2 Diabetes Mellitus","enrollment":218},{"nctId":"NCT05206877","phase":"PHASE1","title":"Topical Insulin for Glaucoma","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-04-01","conditions":"Glaucoma","enrollment":52},{"nctId":"NCT07224893","phase":"PHASE4","title":"Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management","status":"NOT_YET_RECRUITING","sponsor":"Eastern Virginia Medical School","startDate":"2025-12-01","conditions":"Pregestational Diabetes, Pregnancy","enrollment":200},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT05594563","phase":"PHASE2","title":"TArgeting Type 1 Diabetes Using POLyamines (TADPOL)","status":"RECRUITING","sponsor":"Emily K. Sims","startDate":"2023-03-14","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT03617458","phase":"PHASE2","title":"Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Pulmonary Artery Hypertension","enrollment":73},{"nctId":"NCT04044534","phase":"PHASE2","title":"Intranasal Insulin for Posttraumatic Stress Disorder","status":"RECRUITING","sponsor":"VA Connecticut Healthcare System","startDate":"2024-10-31","conditions":"PTSD","enrollment":20},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT01731431","phase":"PHASE3","title":"Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-05-18","conditions":"Diabetes, Gestational","enrollment":914},{"nctId":"NCT05917873","phase":"NA","title":"Metabolic Effects of Four-week Lactate-ketone Ester Supplementation","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-09-07","conditions":"Obesity","enrollment":10},{"nctId":"NCT04475276","phase":"PHASE4","title":"Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2021-02-23","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":120},{"nctId":"NCT06731075","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.","status":"NOT_YET_RECRUITING","sponsor":"Oramed, Ltd.","startDate":"2025-12-15","conditions":"Type 2 Diabetes Mellitus","enrollment":300},{"nctId":"NCT05098470","phase":"PHASE3","title":"Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-03-07","conditions":"Type 2 Diabetes","enrollment":100},{"nctId":"NCT04062890","phase":"PHASE2","title":"Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance","status":"WITHDRAWN","sponsor":"University of Arizona","startDate":"2030-04-15","conditions":"Hyperinsulinism, Insulin Resistance, Insulin Sensitivity","enrollment":""},{"nctId":"NCT04300790","phase":"PHASE2","title":"Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients","status":"COMPLETED","sponsor":"MedSIR","startDate":"2020-10-23","conditions":"Breast Cancer","enrollment":69},{"nctId":"NCT02462161","phase":"PHASE1","title":"Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2015-03-20","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":24},{"nctId":"NCT05970575","phase":"PHASE2","title":"Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury","status":"TERMINATED","sponsor":"Neurological Associates of West Los Angeles","startDate":"2023-12-21","conditions":"Traumatic Brain Injury","enrollment":4},{"nctId":"NCT04621890","phase":"NA","title":"HCT Cash-Only INcentive to Promote Mealtime Insulin DOSE Engagement","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2022-02-14","conditions":"Type 1 Diabetes","enrollment":39},{"nctId":"NCT02879409","phase":"NA","title":"HbA1c Variability in Type II Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Cornell Medical College in Qatar","startDate":"2016-11","conditions":"Diabetes Mellitus Type 2","enrollment":150},{"nctId":"NCT06836128","phase":"PHASE3","title":"The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-03-01","conditions":"Polycystic Ovary Syndrome","enrollment":102},{"nctId":"NCT04055428","phase":"PHASE2","title":"NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2020-08-15","conditions":"Diabetes Mellitus, Cardiovascular Diseases, Insulin Sensitivity/Resistance","enrollment":200},{"nctId":"NCT05153070","phase":"PHASE2","title":"Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09-21","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT05124132","phase":"NA","title":"Resilience and Brain Health of Older Adults (MEDEX-2)","status":"ENROLLING_BY_INVITATION","sponsor":"Washington University School of Medicine","startDate":"2019-04-16","conditions":"Age-related Cognitive Decline","enrollment":468},{"nctId":"NCT06443814","phase":"PHASE2","title":"Multicenter Trial of Meditation and Health Education for Cardiometabolic Disease in Black Women","status":"COMPLETED","sponsor":"Robert Schneider, MD","startDate":"2001-07","conditions":"Atherosclerotic Cardiovascular Disease, Metabolic Syndrome","enrollment":201},{"nctId":"NCT05780151","phase":"PHASE4","title":"Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)","status":"COMPLETED","sponsor":"Mira Zuidgeest","startDate":"2023-07-10","conditions":"Diabetes Mellitus, Type 2","enrollment":107},{"nctId":"NCT04008147","phase":"NA","title":"Hepcidin and Glucose Metabolism","status":"RECRUITING","sponsor":"Swiss Federal Institute of Technology","startDate":"2019-07-03","conditions":"Iron Deficiency Anemia of Pregnancy, Iron Metabolism Disorders, Glucose Intolerance","enrollment":30},{"nctId":"NCT05776862","phase":"PHASE2","title":"Study Testing Benefits of Ursolic Acid (UA) as a Countermeasure To Myopenia and Insulin Resistance in Chronic Spinal Cord Injury (SCI)","status":"COMPLETED","sponsor":"University of Miami","startDate":"2023-03-27","conditions":"Spinal Cord Injuries, Tetraplegia, Paraplegia","enrollment":10},{"nctId":"NCT06959043","phase":"NA","title":"Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes: Plant-based Diet and Physical Exercise","status":"RECRUITING","sponsor":"Maria Elizabeth Rossi da Silva","startDate":"2022-11-22","conditions":"Type 2 Diabetes Mellitus (T2DM), Insulin Resistance, Inflamation","enrollment":60},{"nctId":"NCT06978023","phase":"PHASE2","title":"Novel Chinese Medicine Formula for Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-05","conditions":"Type 2 Diabetes","enrollment":162},{"nctId":"NCT04984226","phase":"PHASE2","title":"Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2023-09-08","conditions":"Chronic Kidney Diseases, Metabolic Acidosis, Fatigue","enrollment":80},{"nctId":"NCT05266417","phase":"PHASE2","title":"Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease","status":"RECRUITING","sponsor":"Gateway Institute for Brain Research","startDate":"2022-02-07","conditions":"Parkinson Disease","enrollment":56},{"nctId":"NCT06946628","phase":"PHASE3","title":"New Triple Therapy in Newly Diagnosed Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-06-01","conditions":"Diabetes Mellitus","enrollment":296},{"nctId":"NCT06893913","phase":"NA","title":"Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-03-01","conditions":"Psoriasis, PreDiabetes, Obesity","enrollment":40},{"nctId":"NCT06671340","phase":"NA","title":"Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Elaine Chow","startDate":"2025-04-02","conditions":"Diabetes Mellitus, Prediabetes / Type 2 Diabetes","enrollment":30},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT04114136","phase":"PHASE2","title":"Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies","status":"RECRUITING","sponsor":"Dan Zandberg","startDate":"2020-09-14","conditions":"Melanoma, NSCLC, Hepatocellular Carcinoma","enrollment":72},{"nctId":"NCT06473662","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects","status":"COMPLETED","sponsor":"Roger New","startDate":"2018-10-22","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":153},{"nctId":"NCT05560971","phase":"NA","title":"Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-01","conditions":"PreDiabetes, Insulin Resistance, Overweight","enrollment":40},{"nctId":"NCT06793904","phase":"NA","title":"Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-02-01","conditions":"Polycystic Ovarian Syndrome (PCOS)","enrollment":122},{"nctId":"NCT00085982","phase":"PHASE2","title":"Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2003-08-21","conditions":"Severe Insulin Resistance","enrollment":11},{"nctId":"NCT06199505","phase":"PHASE2","title":"A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM","status":"COMPLETED","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2023-11-21","conditions":"Type 2 Diabetes","enrollment":153},{"nctId":"NCT06774105","phase":"NA","title":"Stretching and Diabetes","status":"COMPLETED","sponsor":"University of Palermo","startDate":"2024-06-01","conditions":"Type 1 Diabetes (T1D)","enrollment":27},{"nctId":"NCT04321395","phase":"PHASE2","title":"Vigabatrin and Insulin Sensitivity","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-08-23","conditions":"NAFLD, Obesity","enrollment":4},{"nctId":"NCT05384431","phase":"PHASE3","title":"Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study","status":"COMPLETED","sponsor":"Exerkine Corporation","startDate":"2022-08-15","conditions":"Overweight, Obesity","enrollment":51},{"nctId":"NCT06125587","phase":"PHASE2, PHASE3","title":"Chiglitazar/Metformin in Non-obese Women With PCOS","status":"COMPLETED","sponsor":"Shengjing Hospital","startDate":"2023-11-15","conditions":"Polycystic Ovary Syndrome, Chiglitazar, Metformin","enrollment":55},{"nctId":"NCT06741566","phase":"EARLY_PHASE1","title":"Pre-operative Intra-nasal Dexmedetomidine or Insulin for Prevention of Early Post-operative Cognitive Dysfunction in Patients Undergoing Elective Coronary Artery Bypass Graft.","status":"NOT_YET_RECRUITING","sponsor":"Minia University","startDate":"2024-12-27","conditions":"Post Operative Cognitive Dysfunction","enrollment":150},{"nctId":"NCT02514629","phase":"PHASE3","title":"Testosterone, Metformin, or Both, for Hypogonadism in Obese Males","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2013-07-04","conditions":"Hypogonadism, Obesity","enrollment":107},{"nctId":"NCT05768191","phase":"PHASE4","title":"Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin","status":"COMPLETED","sponsor":"Université NAZI BONI","startDate":"2023-06-15","conditions":"Type 1 Diabetes","enrollment":22},{"nctId":"NCT03354390","phase":"PHASE1","title":"HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-07-20","conditions":"Kidney Cancer","enrollment":17},{"nctId":"NCT06704321","phase":"NA","title":"Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD","status":"RECRUITING","sponsor":"Valbiotis","startDate":"2024-01-31","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":70},{"nctId":"NCT05010707","phase":"PHASE2","title":"Transgender Estradiol Affirming Therapy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-08-02","conditions":"Transgenderism","enrollment":39},{"nctId":"NCT00924989","phase":"PHASE3","title":"A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-12-01","conditions":"Adrenocortical Carcinoma","enrollment":139},{"nctId":"NCT01767909","phase":"PHASE2, PHASE3","title":"The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-01-08","conditions":"Amnestic Mild Cognitive Impairment, Alzheimer's Disease","enrollment":240},{"nctId":"NCT06061926","phase":"PHASE2","title":"Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion","status":"RECRUITING","sponsor":"University of Guadalajara","startDate":"2023-05-20","conditions":"Metabolic Syndrome","enrollment":28},{"nctId":"NCT02647827","phase":"PHASE2","title":"Acupuncture or Metformin for Insulin Resistance in Women With PCOS","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2015-12","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Hyperandrogenism","enrollment":303},{"nctId":"NCT06626373","phase":"NA","title":"Elderberry Consumption and Human Health","status":"COMPLETED","sponsor":"Washington State University","startDate":"2023-02-27","conditions":"Obesity, Unspecified","enrollment":18},{"nctId":"NCT06487598","phase":"NA","title":"To Evaluate add-on Effect of Nisha-Amalaki Tablets Along With Insulin on Glycemic Control in Type 1 Diabetes Patients (RCTNA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hirabai Cowasji Jehangir Medical Research Institute","startDate":"2024-07-01","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT03418779","phase":"PHASE2, PHASE3","title":"Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-07-04","conditions":"IgA Nephropathy at High Risk of Developing ESRD","enrollment":60},{"nctId":"NCT06554002","phase":"NA","title":"Acute and Long-term Health Effects of Various Carbohydrates on Blood Glucose Management in Humans","status":"COMPLETED","sponsor":"Singapore Institute of Food and Biotechnology Innovation","startDate":"2019-08-14","conditions":"Nutrition, Healthy","enrollment":98},{"nctId":"NCT04618744","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)","status":"COMPLETED","sponsor":"Oramed, Ltd.","startDate":"2020-11-24","conditions":"Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis","enrollment":32},{"nctId":"NCT05523362","phase":"NA","title":"Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes","status":"COMPLETED","sponsor":"Ian J. Neeland, MD","startDate":"2022-01-15","conditions":"Type 2 Diabetes","enrollment":56},{"nctId":"NCT06449235","phase":"PHASE4","title":"Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh","status":"NOT_YET_RECRUITING","sponsor":"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders","startDate":"2024-09","conditions":"Type2diabetes","enrollment":938},{"nctId":"NCT05227820","phase":"PHASE2","title":"Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia","status":"COMPLETED","sponsor":"Neurological Associates of West Los Angeles","startDate":"2022-01-19","conditions":"Alzheimer Disease","enrollment":23},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT04564846","phase":"PHASE2","title":"A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Oramed, Ltd.","startDate":"2020-11-23","conditions":"Diabetes Mellitus, Type 2","enrollment":49},{"nctId":"NCT04687878","phase":"PHASE2","title":"The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients","status":"COMPLETED","sponsor":"dr.dargahi","startDate":"2020-01-01","conditions":"Parkinson Disease","enrollment":28},{"nctId":"NCT03918148","phase":"","title":"Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2018-01-15","conditions":"Type 2 Diabetes Mellitus","enrollment":1150},{"nctId":"NCT00896298","phase":"PHASE2, PHASE3","title":"Trial of Leptin Replacement Therapy in Patients With Lipodystrophy","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-04","conditions":"Hypoleptinemia, Generalized Lipodystrophy, Partial Lipodystrophy","enrollment":25},{"nctId":"NCT06072963","phase":"PHASE2","title":"COMMETS- Combination MCI Metabolic Syndrome","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-01-30","conditions":"Alzheimer Disease, Mild Cognitive Impairment, Metabolic Syndrome","enrollment":80},{"nctId":"NCT03700801","phase":"PHASE4","title":"Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus","enrollment":130},{"nctId":"NCT04892186","phase":"NA","title":"Effects of Myo-inositol in Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2021-03-26","conditions":"Polycystic Ovary Syndrome, Resistance, Insulin, Glucose Intolerance","enrollment":60},{"nctId":"NCT04153981","phase":"PHASE4","title":"A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2019-12-16","conditions":"Type 2 Diabetes Mellitus","enrollment":304},{"nctId":"NCT03809299","phase":"NA","title":"2-A-Day Study: Twice a Day Meals Study.","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2019-06-20","conditions":"PreDiabetes","enrollment":60},{"nctId":"NCT01970345","phase":"PHASE2","title":"A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-05","conditions":"Autism Spectrum Disorder","enrollment":3},{"nctId":"NCT05679596","phase":"NA","title":"Exogenous Ketosis During Bed Rest in Older Adults","status":"COMPLETED","sponsor":"McGill University","startDate":"2023-02-27","conditions":"Muscle Protein Synthesis, Muscle Atrophy, Insulin Sensitivity","enrollment":30},{"nctId":"NCT06188728","phase":"NA","title":"Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers","status":"COMPLETED","sponsor":"University of Peshawar","startDate":"2020-09-07","conditions":"Metabolic Disease","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":151,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Twice-daily Insulin","genericName":"Twice-daily Insulin","companyName":"Hospital Universitario Dr. Jose E. Gonzalez","companyId":"hospital-universitario-dr-jose-e-gonzalez","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin replaces or supplements the body's own insulin to regulate blood glucose by facilitating glucose uptake into cells and promoting glycogen synthesis. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}